A pharmaceutical company could slow-walk research on medicines Americans need in response to Biden’s recently enacted federal price regulations.
Health Care
As hundreds of thousands lose coverage and face major additional out-of-pocket expenses, private equity enters the spotlight.
As Medicaid redeterminations start up after a long COVID pause, little-known contractor Maximus stands to majorly benefit.
The U.S. health care system is broken and corrupt — our coverage shows we can fix it.
As Medicare becomes increasingly privatized, patients are speaking up about these for-profit insurers’ widespread practice of denying treatments they need.
Now that Biden and Congress have ended pandemic protections, nearly a million have lost Medicaid coverage for procedural reasons so far — and many more will.
Healthcare executives' pay topped $335 million last year while 100 million Americans were saddled with medical debt.
As Medicare privatization continues, insurers are milking massive profits from systematic overbilling and kneecapping modest Biden proposals to stop the scheme.
Rejecting cancer patients’ petition, the Biden administration refuses to use the power its HHS Secretary demanded Trump use.
The pharmaceutical giant, Pfizer, is using Semafor to brag about its generosity abroad as it hikes U.S. drug prices.